Anti COVID-19 drugs: need for more clinical evidence and global action

Z Khan, Y Karataş, H Rahman - Advances in therapy, 2020 - Springer
Abstract The World Health Organization (WHO) called the outbreak of coronavirus infectious
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …

[PDF][PDF] A contemporary look at COVID-19 medications: available and potentially effective drugs

HK Alshaeri, ZS Natto - Eur Rev Med Pharmacol Sci, 2020 - researchgate.net
OBJECTIVE: There have been significant changes to the management of COVID-19 in
recent months, including protocols and guidelines designed to prevent, diagnose, and treat …

Literature-based review of the drugs used for the treatment of COVID-19

M Venkatasubbaiah, PD Reddy… - … medicine research and …, 2020 - Elsevier
COVID-19 is primarily a respiratory disease caused by a newly discovered SARS-CoV-2
virus and identified in the city of Wuhan, China in December 2019. WHO has declared this …

Current drugs with potential for treatment of COVID-19: A literature review: Drugs for the treatment process of COVID-19

MII Rabby - Journal of pharmacy & pharmaceutical …, 2020 - journals.library.ualberta.ca
Purpose: SARS-CoV-2 first emerged in China in December 2019 and rapidly spread
worldwide. No vaccine or approved drug is available to eradicate the virus, however, some …

Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review

JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …

[HTML][HTML] Natural history of COVID-19 and current knowledge on treatment therapeutic options

WG Dos Santos - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Despite intense research there is currently no effective vaccine available against the new
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …

Ongoing clinical trials for the management of the COVID-19 pandemic

MP Lythgoe, P Middleton - Trends in pharmacological sciences, 2020 - cell.com
COVID-19 has rapidly developed into a worldwide pandemic with a significant health and
economic burden. There are currently no approved treatments or preventative therapeutic …

COVID-19: A review of the proposed pharmacological treatments

S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …

Covid-19 and drug therapy, what we learned

A Provenzani, P Polidori - International journal of clinical pharmacy, 2020 - Springer
COVID-19, the disease associated in December 2019 with the novel coronavirus SARS-CoV-
2, was observed for the first time in China and then spread worldwide becoming pandemic …

Clinical management of COVID-19: a review of pharmacological treatment options

AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …